Kleinschnitz, C., Niemczyk, G., Rehberg-Weber, K., & Wernsdörfer, C. (2015). Interferon Beta-1a (AVONEX(®)) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study. Int J Mol Sci.
Citación estilo ChicagoKleinschnitz, Christoph, Gabriele Niemczyk, Karin Rehberg-Weber, y Colin Wernsdörfer. "Interferon Beta-1a (AVONEX(®)) As a Treatment Option for Untreated Patients With Multiple Sclerosis (AXIOM): A Prospective, Observational Study." Int J Mol Sci 2015.
Cita MLAKleinschnitz, Christoph, Gabriele Niemczyk, Karin Rehberg-Weber, y Colin Wernsdörfer. "Interferon Beta-1a (AVONEX(®)) As a Treatment Option for Untreated Patients With Multiple Sclerosis (AXIOM): A Prospective, Observational Study." Int J Mol Sci 2015.